7/11/2023 | DD | Clovis Oncology’s Chapter 11 liquidation plan effective as of July 10
|
6/30/2023 | DD | Clovis Oncology debtors report operating results for May
|
6/16/2023 | DD | Clovis Oncology receives confirmation of amended Chapter 11 plan
|
6/12/2023 | DD | Clovis: U.S. trustee takes issue with fees under proposed settlement
|
6/7/2023 | DD | Clovis reaches settlement with secured lenders, creditors committee
|
6/6/2023 | DD | Clovis’ attempt to disband equity committee denied by court
|
6/5/2023 | DD | Clovis Oncology’s plan, disclosure statement hearing continued
|
6/2/2023 | DD | Clovis Oncology debtors report operating results for April
|
6/2/2023 | DD | Clovis, creditors object to equity committee’s motion for mediation
|
6/1/2023 | DD | Clovis Oncology official equity committee calls for mediation
|
5/30/2023 | DD | Clovis gives plan voting results, equity committee files objection
|
5/24/2023 | DD | Clovis Oncology’s Chapter 11 plan draws objection from U.S. trustee
|
5/18/2023 | DD | Clovis equity holders respond to motion to disband committee
|
5/11/2023 | DD | Clovis hearings set to consider plan confirmation, equity committee
|
5/10/2023 | DD | Clovis’ effort to disband equity committee gets support from creditors
|
5/8/2023 | DD | Clovis Oncology: U.S. trustee appoints official equity committee
|
5/5/2023 | DD | Clovis Oncology wants to disband equity committee with trustee saying ‘not so fast’
|
5/3/2023 | DD | Clovis Oncology debtors report operating results for March
|
5/2/2023 | DD | Clovis Oncology closes sale of Rubraca assets to pharma& Schweiz
|
4/28/2023 | DD | Clovis Oncology wins three-month extension of exclusive plan periods
|
4/21/2023 | DD | Clovis Oncology receives interim approval of disclosure statement
|
4/13/2023 | DD | Clovis Oncology receives OK to sell Rubraca assets to pharma& Schweiz
|
4/11/2023 | DD | Clovis Oncology eyes three-month extension of exclusive plan periods
|
4/4/2023 | DD | Clovis Oncology takes in $116 million winning bid for assets
|
4/3/2023 | DD | Clovis Oncology disclosure statement hearing moved to April 11
|
3/31/2023 | DD | Clovis Oncology debtors report operating results for February
|
3/30/2023 | DD | Clovis Oncology disclosure statement draws committee objection
|
3/29/2023 | DD | Clovis Oncology disclosure statement draws U.S. trustee objection
|
3/22/2023 | DD | Clovis Oncology gets court approval to sell FAP-2286 to Novartis
|
3/20/2023 | DD | Clovis Oncology disclosure statement hearing scheduled for April 4
|
3/17/2023 | DD | Clovis Oncology receives approval of employee bonus program
|
3/15/2023 | DD | Clovis files Chapter 11 plan of liquidation and disclosure statement
|
3/14/2023 | DD | Clovis gets approval of $5.17 million in incremental DIP financing
|
3/8/2023 | DD | Clovis cancels auction for FAP-2286; will seek sale to Novartis
|
3/2/2023 | DD | Clovis Oncology debtors report operating results for January
|
2/28/2023 | DD | Clovis Oncology’s employee bonus program draws U.S. trustee objection
|
2/27/2023 | BKDD | Clovis Oncology seeks $5.17 million of incremental DIP financing
|
2/9/2023 | DD | Clovis Oncology reports $133.46 million net loss for December
|
1/24/2023 | DD | Clovis get approval of $75 million DIP loan and bid procedures
|
1/17/2023 | DD | Clovis’ proposed DIP loan, bid procedures draw objections
|
12/22/2022 | DD | Clovis Oncology trustee forms unsecured creditors committee
|
12/16/2022 | BKCVDDEMHY | Prospect News reports six new defaults for Dec. 8-Dec. 14
|
12/16/2022 | DD | Clovis opts for DIP facility via Sixth Street following auction
|
12/13/2022 | DD | Clovis Oncology details terms of proposed $75 million DIP facility
|
12/12/2022 | BKCVDD | Clovis Oncology files Chapter 11 bankruptcy, plans to sell assets
|
11/9/2022 | CVDD | Clovis Oncology bankruptcy in near term looks ‘increasingly probable’
|
4/13/2016 | DD | Market Commentary: Distressed energy debt rallies on output cut hopes, oil price boost; healthcare converts underperform
|